
TA Associates waltzes to USD 16.5bn fundraise
TA Associates has bucked the fundraising woes faced by many of its peers, clinching a USD 16.5bn final close for its flagship fund after just seven months on the road.
TA XV closed on its hard cap, exceeding its initial target size, after launching in November 2022.
Few sponsors, especially generalist buyout funds, have been able to close multi-billion funds in the current macro-environment, with LPs squeezed for commitments.
The fund is 32% larger than its predecessor, TA XIV, which closed in June 2021 at its hard cap of USD 12.5bn. KKR raised USD 8bn for its latest European fund, including a 12.5% GP commitment, while Permira hit EUR 16.7bn in March.
Other expected multi-billion fundraises are in slow in the pipeline, with Astorg cutting its flagship fundraising target by EUR 2bn.
The sponsor will invest across the technology, healthcare, financial services, consumer and business services sectors.
In Europe, the sponsor recently acquired a minority stake in German insurance broker MRH Trowe, as well as circling TeamSystem and ESI Group.
Investors
TA XV received capital commitments from a diverse global network of existing and new investors, including public and private pension funds, sovereign wealth funds, asset managers, endowments, foundations, family offices and insurance companies.
Advisors
TA Associates - Goodwin Procter (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater